The next iteration of Biotech megarounds is underway. Hear how this will impact the industry.

Klicken Sie hier, um Fiercebiotech.com zu abonnieren

Laden...

11 Monate vor

Html
Text

The rumors of the IPO window opening have been greatly exaggerated, but the green shoots are there. Instead of rushing for the public markets "à la 2021", private biotechs are conducting financing extensions and we’re starting to see megarounds once again.

Join Fierce Biotech staff writer Gabrielle Masson at Fierce JPM Week in San Francisco on January 9-10th, as she delves into this topic with a panel of experienced executives who are seeing this trend playout in real-time.

We’ll look at the innovative ways companies are holding off on an IPO and how that’s impacting the industry. We’ll also look at how companies that have made the plunge recently are faring—and what their success or failure says for the rest of the industry.

VIEW THE AGENDA>>

Join over 500 senior biotech and pharma executives at this one-of-a-kind event focused on learning, networking and connecting!

Register now and save $200 with the Advanced Rate! Prices increase December 22nd.

Featured Session

Crossovers, Megarounds and IPOs: Biotechs Always Find a Way

MODERATOR

Gabrielle Masson

Staff Writer

Fierce Biotech

Kristine Ball

CEO

Antiva Biosciences Inc

Ken Song

CEO

RayzeBio

Julie Grant

General Partner

Canaan

Jackie Spencer

Head of Relationship Management for Life Science and Healthcare Banking

Silicon Valley Bank

Jun Yoon

CFO

Structure

VIEW THE AGENDA

Special Offer on Group Rates!

Send Your Team and Save
Send your team (3 or more) and each member of your team can register for just $595/person with code JPMGROUP.*

DEADLINE: December 8, 2023

*PLEASE NOTE: This offer is only available to qualified Pharma, Biotech and Medical Device companies and requires a team of 3 or more. Your team must be registered by December 8th or you will be required to pay the current price at the time that you registered.

Learn About Partnership Opportunities

3,500+

Virtual Attendees

500+

In-Person Attendees

75%

VP Level and Above

2 Days

Great Content and Opportunities to Network

Position your company as a thought leader, promote your brand and engage with leading Biotech and Pharma Executives. Contact us today to learn why Fierce JPM Week is the right show for you!

BECOME A PARTNER

Thank You to Our Partners

If you no longer wish to receive promotion on this event, simply unsubscribe.
Refer to our Privacy Policy.
Fierce Life Sciences is a division of Questex LLC.
685 3rd Ave 21st Floor New York, NY 10017

Teilen auf

Laden...

Weitere Newsletter von Fiercebiotech.com

| 11.23.24 | House passes sweeping nonprofits bill; Trump taps Dr. Oz to run CMS Fiercebiotech.com
Gestern um 13:32
| 11.22.24 | Halozyme ends $2B pursuit of 'unwilling' Evotec; Lexicon cuts 60% of workforce Fiercebiotech.com
Gestern um 20:32
| 11.22.24 | Rett patient dies in Neurogene trial; AZ scraps opioid disorder drug over antifungal interaction Fiercebiotech.com
Letzten Freitag um 17:35

Weitere Newsletter von Fiercebiotech.com

Laden...

The next iteration of Biotech megarounds is underway. Hear how this will impact the industry.

Teilen auf

Weitere Newsletter von Fiercebiotech.com

Verwandte Newsletter